Evidence map›Paper›PMID 42818854›Full record

ArticleFrontiers in nutrition2026

Effects of caffeinated chewing gum on prolonged repeated-sprint performance in normobaric hypoxia.

Jin Huang, Yuean Yang, Ruiguo Xue, Linyin Xu, Jingxin Liu, Jue Liu, Yinhang Cao

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jin HuangSchool of Athletic Performance, Shanghai University of Sport, Shanghai, China.
Yuean YangDepartment of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Ruiguo XueSchool of Athletic Performance, Shanghai University of Sport, Shanghai, China.
Linyin XuFaculty for Physical Education, Shanghai International Studies University, Shanghai, China.
Jingxin LiuSchool of Physical Education, Shanghai University of Sport, Shanghai, China.
Jue LiuDepartment of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Yinhang CaoSchool of Athletic Performance, Shanghai University of Sport, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to investigate the effects of caffeinated chewing gum on performance during a prolonged intermittent-sprint test (IST) under normobaric hypoxia. Methods: Ten team-sport athletes (six men and four women) participated in a double-blind, randomized crossover trial with a counterbalanced treatment order, chewing either caffeinated gum (6 mg/kg) or placebo gum on two separate occasions, 7 days washout period. After chewing for 10 min, participants performed an IST protocol in hypoxia (inspired oxygen fraction: 16.5 ± 0.2%, ~2,000 m). The IST consisted of two 40-min halves separated by a 15-min halftime recovery, each comprising twenty 2-min blocks with an 8-s all-out sprint, 100 s of active recovery at 35% of peak oxygen uptake, and 12 s of passive rest. Total work done, power output, muscle and cerebral oxygenation were recorded. Results: Total work done was significantly greater with caffeinated gum, increasing by 4.4% in the first half [mean difference = 6 kJ, 95% CI (2.71, 10.08)] and a 2.9% increase in the second half [mean difference = 4 kJ, 95% CI (1.18, 6.57)] compared to placebo (all Conclusion: Caffeinated chewing gum (6 mg/kg) enhances prolonged repeated-sprint performance under normobaric hypoxia, accompanied by increased cerebral oxygenation and muscle reoxygenation capacity.

Indexed as

caffeinated chewing gumergogenic aidshypoxiarepeated-sprint abilityteam sports

Identifiers

PMID42818854
PMCPMC13624110

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.